Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2022 11:45 ET | Source: Deinove

Issuance of 3rd tranche of €500,000 of notes convertibles into new shares

Issuance of 3rd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its working capital needs and the pursuance of the Phase II clinical trial...
January 26, 2022 11:45 ET | Source: Deinove

Émission d’une 3ème tranche d’OC de 500.000€

Émission d’une 3ème tranche d’OC de 500.000€ DEINOVE renforce sa trésorerie pour financer son besoin en fonds de roulement et la poursuite de l’essai clinique de Phase II évaluant DNV3837 dans les...
December 15, 2021 11:45 ET | Source: Deinove

Issuance of 2nd tranche of €500,000 of notes convertibles into new shares

Issuance of 2nd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its working capital needs and the pursuance of the Phase II clinical trial...
December 15, 2021 11:45 ET | Source: Deinove

Émission d’une 2ème tranche d’OC de 500.000€

Émission d’une 2ème tranche d’OC de 500.000€ DEINOVE renforce sa trésorerie pour financer son besoin en fonds de roulement et la poursuite de l’essai clinique de Phase II évaluant DNV3837 dans les...
January 20, 2021 12:45 ET | Source: Deinove

Issuance of a 5th tranche of 3 millions EUR of notes convertible into new shares

ISSUANCE OF A 5th TRANCHE OF 3 MILLIONS EUR OF NOTES CONVERTIBLE INTO NEW SHARES DEINOVE strengthens its cash position to finance the ongoing clinical trial testing DNV3837 for the treatment of...
January 20, 2021 12:45 ET | Source: Deinove

Emission d’une 5ème tranche d'OCA de 3 m€

EMISSION D’UNE 5ème TRANCHE D'OCA DE 3 M€ DEINOVE renforce sa trésorerie pour financer la poursuite de l’essai clinique de DNV3837 dans le traitement des infections gastro-intestinales sévères...
January 01, 2021 19:15 ET | Source: The Rosen Law Firm PA

ICPT FINAL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT

NEW YORK, Jan. 01, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
December 10, 2020 17:28 ET | Source: The Rosen Law Firm PA

ROSEN, A GLOBAL AND LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action – ICPT

NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...
December 03, 2020 19:45 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ICPT

NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) between...